MedPath

Expiratory flow limitation via 'Flow-Limiter': A feasability study wth spontaneously breathing, lung healthy volunteers

Not Applicable
Conditions
Modulation of the expiration during spontanous breathing comparable to pursed lip breathinglung healthy volunteers
Registration Number
DRKS00015296
Lead Sponsor
Klinik für Anästhesiologie und Intensivmedizin Universitätsklinikum Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
31
Inclusion Criteria

lung healthy

Exclusion Criteria

known cardiocirculatory diseases, known lung diseases, pregnancy, active implants

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tolerable expiratory flow limitation, rated by the volunteer directly after the experiment.
Secondary Outcome Measures
NameTimeMethod
Expiratory peak flow, measured by pneumotachography as mean for the duration of the experiment. Regional ventilation, measured by electrical impedance tomography as a mean for the duration of the experiment. Subjective perception, rated by the volunteer as forced choice (better/worse), directly after the experiment.
© Copyright 2025. All Rights Reserved by MedPath